Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday SpaceX and OpenAI Potential Public Debuts May Surpass Berkshire Hathaways Market Cap on Day One New York Fed Study Reveals LowerIncome Households Bear Brunt of Rising Gas Prices Snowflake Stock Surges on Enterprise AI Adoption and AWS Collaboration Ebola Outbreak in DRC Raises Concerns Over Healthcare Resources and Regional Economic Stability Kazatomprom Reports 17 Production Surge in Third Quarter Potentially Impacting Uranium Supply FLYW Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment Despite Modest Stock Decline DMLP Q4 2024 Earnings Limited Partnership Reports EPS of 024 Amid Steady Operations Commvault Systems Inc CVLT Q1 2026 Earnings EPS Surges Past Expectations as Cloud Growth Momentum Continues LSAK Q1 2026 Earnings Massive EPS Beat Signals Strong Profitability Surge PRHI Q1 2024 Earnings Significant EPS Beat Fails to Impress Markets OPBK Q1 2026 Earnings EPS Surpasses Estimates by 146 Canadian Pacific Kansas City CP Surges 332 on Heavy Volume Key Levels in Focus Blackrock MuniYield Quality Fund MQY Nudges Up Slightly on Modest Trading SC II Acquisition Corp SCII Holds Steady at 1001 Amid Minimal Movement Xeris Biopharma XERS Drops 298 Testing Key Support Near 588 CurtissWright Holds Steady Above Support A Look at Key Levels Teradata Chief Product Officer Sells 15000 Shares Insider Transaction Analysis SANM Q1 2026 Earnings Strong EPS Beat Drives Stock Rally Artivion Inc AORT Slides 136 as Stock Tests Key Support Levels Amid Sector Headwinds International Seaways Q1 2026 Earnings Strong EPS Beat Signals Robust Tanker Market TOWN Q1 2026 Earnings EPS Misses Estimates by Nearly 5 Stock Edges Lower PGEN Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher Fluent Inc Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty Mistras Group MG Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction OXLCZ Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control